Imagicaaworld Entertainment (NSE: IMAGICAA) bets on indoor format as Hello Park launch targets Hyderabad’s urban families
Imagicaaworld Entertainment launches India's first Hello Park in Hyderabad. What the indoor phygital pivot means for IMAGICAA's revenue and stock. Read more.
EV Resources (ASX: EVR) consolidates Don Enrique copper project to 100%, unlocking 2,684-ha Peru land package
EV Resources (ASX: EVR) consolidates full ownership of Peru's Don Enrique copper-silver project. Drill-ready, 2,684ha, porphyry potential. Read the full analysis.
Keysight Technologies (NYSE: KEYS) targets AI networking bottlenecks with new 1.6T Ethernet validation platform
Keysight Technologies unveils AresONE 1600GE to test 1.6T Ethernet AI networks. Discover why hyperscale data centers may depend on this next-gen validation platform.
The real reason Meta paid for Moltbook: not the product, but who controls how AI agents find each other
Meta Platforms acquires Moltbook to build AI agent infrastructure inside its Superintelligence Labs. What the deal really signals for the future of autonomous AI. Read more.
Aramco CEO says 6.7 million barrels a day lost as Hormuz shutdown surpasses every prior Gulf energy crisis
Saudi Aramco CEO Amin Nasser warns of catastrophic consequences for global oil markets as the Strait of Hormuz crisis deepens. Read our full analysis.
Google-backed IPX Power launches with 4.4 GW solar portfolio after Intersect restructuring
IPX Power launches with 4.4 GW of solar and 8.8 GWh of battery storage after the Intersect–Google deal. Discover why investors are watching the new energy player.
Minda Corporation (NSE :MINDACORP) signs EV powertrain JV with UK’s Turntide Drives for India market
Minda Corporation (MINDACORP) signs EV powertrain JV with UK's Turntide for axial flux motors and controllers. What it means for India's EV supply chain. Read more.
Is enterprise AI finally getting a security rulebook? UiPath (NYSE: PATH) just passed the first real test
UiPath becomes the first automation platform to earn AIUC-1 certification. Discover why the new AI agent security standard could reshape enterprise automation.
Atos Group posts doubled operating margin in FY2025 as Genesis restructuring plan delivers ahead of schedule
Atos Group doubles FY2025 operating margin to 4.4% and meets all targets. Genesis plan executes ahead of schedule. Read the full analysis.
GSK to sell linerixibat rights to Alfasigma for up to $690m as rare liver disease drug nears FDA approval
GSK and Alfasigma agree worldwide licence for linerixibat, a rare liver disease itch drug nearing FDA approval. Deal worth up to $690 million. Read more.